| Diabetes drug safety boost - Pharmacy News |
|
|
Pharmacy News“Currently available DPP-4 inhibators are mainly eliminated via the kidney and therefore not recommended in patients with advanced renal impairment. ...New data support safety profile of diabetes drug Nursing in PracticeBoehringer Ingelheim reports phase III data for diabetes drug ZenopaBoehringer Ingelheim Presents New Phase III Data Evaluating Linagliptin in ... read more |